April coverage recounts an earlier campaign

The interview discussed Ghana’s centre for plant-based medicine and links with universities.

Yirenkyi described professional training, registration and quality oversight.

A news release described a March vaccination campaign using Men5CV against five meningococcal groups.

The article explains why vaccination was undertaken in affected Nigerian states.

Men5CV can protect against several causes of meningococcal meningitis, depending on the group.

WHO prequalified the TAK-003 dengue vaccine on 10 May, later reporting the decision.

The prequalification supports procurement for countries with appropriate dengue vaccine policies.

The vaccine is recommended for children in particular high-transmission settings, not for every population.

The decision was one step in dengue prevention alongside mosquito control and clinical care.

New regional guidance outlined ways to improve management of sickle cell disease.